The Nectin-4 NDC exhibited excellent specificity and high cellular uptake in cancer cells with elevated Nectin-4 expression, and effectively inhibited GC progression in vivo in a dose-dependent manner (Wu et al., 2024). Here, NECTIN4 is linked to cancer.